top of page
Clinical Trials are Recruiting!
current as of October 11, 2026, check clinicaltrials.gov to confirm
Alzheimer's Disease Trials
Remternetug
-
Sponsor: DIAN-TU / Washington University-linked autosomal dominant Alzheimer's network
-
Trial ID: NCT06647498
-
Who it is for: Asymptomatic people at risk because of Alzheimer's disease-causing mutations
-
Link: https://clinicaltrials.gov/study/NCT06647498
CpG 1018 ISS
-
Sponsor: NYU Alzheimer's Disease Research Center
-
Trial ID: No NCT listed in the initial search
-
Who it is for: Mild cognitive impairment or mild Alzheimer's dementia; immune-stimulation approach
-
Links: https://med.nyu.edu/centers-programs/alzheimers-disease-research/research/clinical-trials,
https://clinicaltrials.gov/study/NCT06976216
VHB937
-
Sponsor: Novartis Pharmaceuticals
-
Trial ID: NCT07094516
-
Who is it for: People with early Alzheimer's disease
-
Link: https://clinicaltrials.gov/study/NCT07094516
Parkinson's Disease Trials
GT-02287
-
Sponsor: Gain Therapeutics
-
Trial ID: NCT07280299
-
Who is it for: Patients with early Parkinson's disease
-
Links: learn more, https://clinicaltrials.gov/study/NCT07280299
Prasinezumab
-
Sponsor: Roche / Genentech and Prothena
-
Trial ID: NCT07174310
-
Who it is for: Early-stage Parkinson's disease
-
Link: https://clinicaltrials.gov/study/NCT07174310
Bemdaneprocel
-
Sponsor: BlueRock Therapeutics / Bayer
-
Trial ID: NCT06944522
-
Who it is for: Parkinson's disease; dopaminergic cell therapy compared with sham surgery
-
Link: https://clinicaltrials.gov/study/NCT06944522
Buntanetap
-
Sponsor: Annovis Bio
-
Trial ID: NCT07284784
-
Who it is for: Parkinson's disease
-
Link: https://clinicaltrials.gov/study/NCT07284784
Prasinezumab
-
Sponsor: Roche / Genentech
-
Trial ID: NCT07055087
-
Who it is for: Parkinson's disease with GBA-related cognitive-risk focus
-
Verify: https://clinicaltrials.gov/study/NCT07055087
ALS / FTD Trials
Pridopidine
-
Sponsor: Prilenia
-
Trial ID: NCT07322003
-
Who it is for: Adults with ALS
-
Link: https://clinicaltrials.gov/study/NCT07322003
COYA-302
-
Sponsor: Coya Therapeutics
-
Trial ID: NCT07161999
-
Who is it for: Adults with ALS
-
Link: https://clinicaltrials.gov/study/NCT07161999
VTx-002
-
Sponsor: Vector Y Therapeutics
-
Trial ID: NCT07287397
-
Who is it for: Adults with ALS
-
Link: https://clinicaltrials.gov/study/NCT07287397
AMX0114
-
Sponsor: Amylyx Pharmaceuticals
-
Trial ID: NCT06665165
-
Who is it for: Adults with ALS
-
Link: https://clinicaltrials.gov/study/NCT06665165
Tofersen in non-SOD1 ALS
-
Sponsor: Washington University School of Medicine
-
Trial ID: NCT07294144
-
Who is it for: Adults with ALS not caused by mutations in SOD1
-
Link: https://clinicaltrials.gov/study/NCT07294144
AVB-101, ASPIRE-FTD
-
Sponsor: AviadoBio
-
Trial ID: NCT06064890
-
Phase/status: Phase 1/2; recruiting
-
Who it is for: FTD-GRN gene therapy; U.S. site at Ohio State reported
-
Link: https://clinicaltrials.gov/study/NCT06064890
Multiple Sclerosis Trials
Frexalimab
-
Sponsor: Sanofi
-
Trial ID: NCT07325292
-
Who it is for: Relapsing MS and non-relapsing SPMS; subcutaneous vs IV administration
-
Link: https://www.sanofi.com/en/clinical-trials/nct07325292
Orelabrutinib
-
Sponsor: InnoCare
-
Trial ID: NCT07067463
-
Who it is for: Primary progressive or progressive multiple sclerosis, depending on site
-
Link: https://clinicaltrials.gov/study/NCT07067463
Huntington's Disease Trials
Pridopidine
-
Sponsor: Prilenia
-
Trial ID: NCT07609108
-
Who is it for: Adults with Huntington's Disease
-
Link: https://clinicaltrials.gov/study/NCT07609108
hNSC-01
-
Sponsor: Leslie Thompson, University of California Irvine
-
Trial ID: NCT07451613
-
Who is it for: Adults with Huntington's Disease
-
Link: https://clinicaltrials.gov/study/NCT07451613
Votoplam
-
Sponsor: Novartis
-
Trial ID: NCT07326709
-
Who it is for: Early symptomatic Huntington's disease
-
Links: https://www.novartis.com/clinicaltrials/study/nct07326709, https://clinicaltrials.gov/study/NCT07326709
SKY-0515
-
Sponsor: Skyhawk Therapeutics
-
Trial ID: NCT07378644
-
Who it is for: Huntington's disease
-
Link: https://clinicaltrials.gov/study/NCT07378644
Stroke and Ischemic Brain Injury Trials
ASP2246
-
Sponsor: Astellas
-
Trial ID: NCT07318714
-
Who it is for: Chronic post-stroke motor impairment
-
Link: https://clinicaltrials.gov/study/NCT07318714
NEUROVINC
-
Sponsor: National University Hospital, Singapore
-
Trial ID: NCT05679739
-
Who it is for: Acute ischemic stroke / cerebral blood-flow strategy
-
Link: https://clinicaltrials.gov/study/NCT05679739
Inhaled nitric oxide during thrombectomy
-
Sponsor: Wake Forest University
-
Trial ID: NCT05871606
-
Who it is for: Acute ischemic stroke undergoing clot retrieval
-
Links: https://www.withpower.com/trial/phase-1-ischemic-stroke-5-2023-7e3c0, https://clinicaltrials.gov/study/NCT05871606
Traumatic Brain Injury Trials
-
Sponsor: Northwestern University
-
Trial ID: NCT07166393
-
Who it is for: Moderate-to-severe TBI
CIPN Trials
SIR2501
-
Sponsor: Sironax
-
Trial ID: NCT07765446
-
Phase/status: Phase 1b/2 ongoing per company
-
Who it is for: CIPN and ALS development program
-
Link: https://www.sironax.com/sironaxs-sarm1-inhibitor-sir2501-granted-fda-fast-track-designation-in-chemotherapy-induced-peripheral-neuropathy-cipn-2/
Psilocybin
-
Sponsor: M.D. Anderson Cancer Center
-
Trial ID: NCT07227909
-
Who it is for: Prevention or mitigation of CIPN during chemotherapy
-
Link: https://clinicaltrials.gov/study/NCT07227909
Spinal cord stimulation
-
Sponsor: Assistance Publique Hopitaux De Marseille
-
Trial ID: NCT07579611
-
Who it is for: Painful CIPN
-
Link: https://clinicaltrials.gov/study/NCT07579611
Spinal cord stimulation for CIPN
-
Sponsor: Mayo Clinic
-
Trial ID: NCT05411523
-
Who it is for: Painful CIPN / cancer-related neuropathic pain
-
Link: https://www.mayo.edu/research/clinical-trials/cls-20530343
CMT and Peripheral Neuropathy Trials
CMT natural history and genetics
-
Sponsor: Inherited Neuropathies Consortium
-
Trial ID: NCT01193075 / NCT01193088
-
Who it is for: CMT natural history, genetic modifiers, and trial readiness
-
Link: https://clinicaltrials.gov/study/NCT01193088
Friedreich's Ataxia Trials
Nomlabofusp
-
Sponsor: Larimar Therapeutics
-
Trial ID: NCT06447025
-
Who it is for: Friedreich's ataxia
-
Link: https://clinicaltrials.gov/study/NCT06447025
bottom of page